Hangjun Zhan

Hangjun Zhan is currently the Chief Technology Officer at Attovia Therapeutics. Prior to that, Hangjun held positions as CSO at Alamar Biosciences, Inc. and KindredBio. With a background in Biochem and a Ph.D. from the University of Washington, Hangjun has extensive experience in the biotech industry, including roles at Aragen Bioscience, Exelixis Inc, and Celera Genomics.